Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality by Huiqiao Fan, Youssef Bessada, Craig I. Coleman

Subjects: Get full text

Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel by Gregory J. Fermann, Brooks D. Cash, Nayantara Coelho‐Prabhu, Marc Maegele, Roland Bingisser, Vinay Sehgal, Alexander T. Cohen, Anna Hundt Golden, Jon Russo, Mark Price, Allen Mangel, Bruce Koch, Mary J. Christoph, Truman J. Milling Jr.

Subjects: Get full text

Andexanet alfa: trials just leave us with more questions by Richard J. Buka

Subjects: Get full text

Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism by Masashi Yoshida, Kentaro Ejiri, Naoaki Matsuo, Takanori Naito, Kazuhiro Kuroda, Koji Tokioka, Kunihiko Hatanaka, Ryohei Fujimoto, Hidenaru Yamaoka, Yutaka Kajikawa, Kazuki Suruga, Hiroki Sugiyama, Tsuyoshi Miyaji, Yoshimasa Morimoto, Nobuhiro Okamura, Toshihiro Sarashina, Satoshi Akagi, Toru Miyoshi, Kazufumi Nakamura, Hiroshi Ito, Shinsuke Yuasa

Subjects: “…Factor Xa inhibitors…”
Get full text

Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries by James M. Williams, Belinda Lovelace, Mary J. Christoph, Suying Li, Haifeng Guo, Madison Hoover, Craig I. Coleman

Subjects: Get full text

Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2 by Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Takeshi Inoue, Shunsuke Usami, Po-Min Chen, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Kosuke Doi, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Tomohiro Dohke, Toru Sato, Ryusuke Nishikawa, Takeshi Kimura, Kaoru Dohi

Subjects: Get full text

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis by Ceyda Tanoğlu, Alevtina Ersoy

Subjects: Get full text

Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study by Maha A.T. Elsebaie, Zoe Wickham, Stephanie DeBragga, Stacey Fedewa, Mohamed Amgad, Jane Jungyoon Park, Allen Li, Ali Eshaghpour, Juan Li, Mark Crowther, Manila Gaddh

Subjects: Get full text

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis by Jin Xiong, Hongmei Jian, Zhenzhou Yang, Lei Xia

Subjects: Get full text

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volun... by Alexander Lenard, Simon A. Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I. Foerster, David Czock, Gerd Mikus, Andreas D. Meid, Walter E. Haefeli, Antje Blank

Subjects: “…factor Xa inhibitors…”
Get full text

Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observat... by Paul P. Dobesh, Craig I. Coleman, Mark Danese, Eva Lesén, Raymond C. Chang, Onivefu Odelade, Gregory J. Fermann

Subjects: Get full text

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES by Z. M. Safiullina, S. V. Shalaev

Subjects: “…direct inhibitor of coagulation factor xa…”
Get full text

Investigating interassay variability between direct oral anticoagulant calibrated anti–factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation... by Ryan M. Baker, Rita Selby, Karen A. Moffat, Melanie St John, Alex C. Spyropoulos, Sam Schulman, James Douketis

Subjects: Get full text

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antip... by N. V. Seredavkina, T. M. Reshetnyak, N. M. Kosheleva, A. M. Lila

Subjects: “…factor xa inhibitors…”
Get full text

Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring by Merijn C. Reuland, Thijs F. van Haaps, Pieter O.L.P. Broeren, Nick van Es, Claire E. Dijkslag-van der Laan, Alexander P.J. Vlaar, Michiel Coppens, Marcella C.A. Müller

Subjects: Get full text

Brazilian guidelines for the pharmacological treatment of pulmonary embolism. Official document of the Brazilian Thoracic Association based on the GRADE methodology by Veronica Moreira Amado, Caio Júlio César dos Santos Fernandes, William Salibe-Filho, Marcelo Basso Gazzana, Ana Thereza Rocha, Hugo Hyung Bok Yoo, Wanderley Marques Bernardo, Suzana Tanni

Subjects: Get full text

Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry by Danielle T. Vlazny, Robert D. McBane, Ana I. Casanegra, David O. Hodge, Teresa Lang, Waldemar E. Wysokinski, Lisa Peterson, Damon E. Houghton

Subjects: Get full text

Deep vein thrombosis prophylaxis in patients who undergo knee arthroscopy: a systematic review by Udit Dave, Emma G. Lewis, Victoria K. Ierulli, Shreya M. Saraf, Mary K. Mulcahey

Subjects: Get full text

Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study by Krister Johansson, Jonas P Becktor, Aron Naimi-Akbar, Peter J Svensson, Bengt Götrick

Subjects: Get full text

Anticoagulants: dose control methods and inhibitors by V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris, A. D. Makatsariya

Subjects: Get full text